Hughes Steven George

CIK 00017475284 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001747528

Recent Transactions

49 trades

Award
Atrium Therapeutics, Inc.$RNA
Common Stock
2026-04-20+30,000→ 73,097 total
Award
Atrium Therapeutics, Inc.$RNA
Stock Option (Right to Buy)
2026-04-20+60,000→ 60,000 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-02-27−115,857→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−73,342→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−74,000→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−49,333→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−68,458→ 0 total
Disposition to Issuer
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2026-02-27−50,000→ 0 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-21$72.45/sh−2,017→ 34,477 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-21$72.45/sh−2,878→ 31,599 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2026-01-07$72.23/sh−2,373→ 36,494 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-10-22$10.16/sh+2,209→ 41,076 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-10-22$47.54/sh−2,209→ 38,867 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-10-22−2,209→ 68,458 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-09-22−2,208→ 70,667 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-22$40.58/sh−2,208→ 38,867 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-22$10.16/sh+2,208→ 41,075 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-15$6.57/sh+1,542→ 40,409 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-09-15$45.41/sh−1,542→ 38,867 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-09-15−1,542→ 49,333 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-22$10.16/sh+2,208→ 41,075 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-22$46.40/sh−2,208→ 38,867 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-22−2,208→ 72,875 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-13$6.57/sh+1,542→ 40,409 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-13$46.66/sh−1,542→ 38,867 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-13−1,542→ 50,875 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$42.74/sh−33,983→ 38,867 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-06−11,283→ 73,342 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-06−12,334→ 52,417 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$15.96/sh+11,283→ 84,133 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$42.74/sh−11,283→ 72,850 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$6.57/sh+12,334→ 85,184 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$10.16/sh+17,667→ 90,517 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$42.74/sh−17,667→ 72,850 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$22.47/sh+6,167→ 79,017 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-06−17,667→ 75,083 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$42.74/sh−6,167→ 72,850 total
Exercise/Conversion
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-08-06−6,167→ 74,000 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-08-06$42.74/sh−12,334→ 72,850 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-03-20$31.06/sh−9,578→ 72,850 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-21$28.59/sh−2,032→ 82,428 total
Sale
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-21$28.60/sh−1,915→ 84,460 total
Award
Avidity Biosciences, Inc.$RNAM
Common Stock
2025-01-06+25,000→ 86,375 total
Award
Avidity Biosciences, Inc.$RNAM
Stock Option (Right to Buy)
2025-01-06+50,000→ 50,000 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock Option (right to buy)
2020-12-18+50,000→ 50,000 total
Award
Arcturus Therapeutics Holdings Inc.$ARCT
Stock Option (right to buy)
2020-02-18+75,000→ 75,000 total
Sale
VivoSim Labs, INC.$VIVS
Common Stock
2019-08-16$0.29/sh−22,230→ 138,484 total
Award
VivoSim Labs, INC.$VIVS
Common Stock
2018-08-14+160,714→ 160,714 total
Award
VivoSim Labs, INC.$VIVS
Stock Option (Right to Buy)
2018-08-14+974,694→ 974,694 total

Companies

Recent Filings

Address

C/O ATRIUM THERAPEUTICS, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125

SAN DIEGO, CA, 92121

View on SEC.gov